Close

Merck KGaA Reports FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

December 10, 2018 10:10 AM EST Send to a Friend
Merck KGaA, Darmstadt, Germany, a leading science and technology company, which operates its healthcare business in the U.S. and Canada ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login